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Inhibition of airway surface 
fluid absorption by cholinergic 
stimulation
Nam Soo Joo1, Mauri E. Krouse1,†, Jae Young Choi1,2, Hyung-Ju Cho1,2 & Jeffrey J. Wine1
In upper airways airway surface liquid (ASL) depth and clearance rates are both increased by fluid 
secretion. Secretion is opposed by fluid absorption, mainly via the epithelial sodium channel, ENaC. 
In static systems, increased fluid depth activates ENaC and decreased depth inhibits it, suggesting 
that secretion indirectly activates ENaC to reduce ASL depth. We propose an alternate mechanism in 
which cholinergic input, which causes copious airway gland secretion, also inhibits ENaC-mediated 
absorption. The conjoint action accelerates clearance, and the increased transport of mucus out of 
the airways restores ASL depth while cleansing the airways. We were intrigued by early reports of 
cholinergic inhibition of absorption by airways in some species. To reinvestigate this phenomenon, 
we studied inward short-circuit currents (Isc) in tracheal mucosa from human, sheep, pig, ferret, 
and rabbit and in two types of cultured cells. Basal Isc was inhibited 20–70% by the ENaC inhibitor, 
benzamil. Long-lasting inhibition of ENaC-dependent Isc was also produced by basolateral carbachol 
in all preparations except rabbit and the H441 cell line. Atropine inhibition produced a slow recovery or 
prevented inhibition if added before carbachol. The mechanism for inhibition was not determined and 
is most likely multi-factorial. However, its physiological significance is expected to be increased mucus 
clearance rates in cholinergically stimulated airways.
In human airways, mucociliary and cough clearance are critical components of mucosal innate defense1,2. Mucus 
clearance requires an adequate fluid layer lining the airways, and this is maintained by a balance of electrogenic, 
anion-mediated fluid secretion and Na+-mediated fluid absorption, the latter mediated mainly via the epithelial 
sodium channel, ENaC1,3. A fundamental question in airway physiology is how airways orchestrate these oppos-
ing forces. This question has mainly been explored in cultured surface epithelia, where it has been shown that 
cells respond to changes in the fluid volume covering them, resulting in a homeostatically controlled depth4,5. 
However, in upper airways, submucosal glands provide an additional and powerful component of secretion to 
the airways6, and in all airways, the rate of mucus transport provides another mechanism for adjusting the depth 
of airway surface liquid (ASL). In this paper, we consider what occurs when airways are stimulated choliner-
gically, and reconsider early experiments that showed dual actions of cholinergic stimuli on airway epithelia. 
We propose that in addition to promoting gland secretion, cholinergic inhibition of surface epithelial sodium 
absorption promotes increased surface fluid volume from the epithelia themselves. Because increased ASL depth 
leads to increased mucus transport rates7,8, these coordinated secretory mechanisms will enhance clearance. Thus, 
increased mucus clearance rate is an additional homeostatic mechanism to restore ASL depth in addition con-
comitant with its main function of cleansing the airways.
In Ussing chamber experiments with short-circuited epithelia, the Isc across unstimulated airways of most 
species is dominated by sodium absorption through ENaC, so that large drops in Isc occur when ENaC is blocked. 
When studying the effects of agonists such as acetylcholine (ACh), most investigators first block ENaC, allow-
ing them to focus on anion secretion. However, Na+ absorption by at least some airway surface epithelia is also 
affected by ACh. Al-Bazzaz and colleagues9,10, showed a biphasic response to basolateral carbachol in sheep bron-
chioles. They observed an initial transient Isc increase followed by a long-lasting decrease due to inhibition of Na+ 
transport. They suggested that ACh-induced inhibition of Na+ absorption resulted from increased [Ca2+]i, based 
on their prior work measuring Isc and ion fluxes across dog trachea, where it was shown that the Ca2+ ionophore, 
A23187, abolished Na+ transport in a Ca2+-dependent fashion11. In excised human bronchi, 0.1 mM ACh caused 
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an Isc decrease, and net Na+ absorption was abolished12. ACh also induced an electrically silent flow of Na+ 
and Cl-, which they inferred was attributed to submucosal gland secretion. Inhibition of ENaC-mediated Isc by 
increased [Ca2+]i was subsequently shown in cultured mouse endometrial cells, where ATP was used to elevate 
[Ca2+]i13. Airway ciliated cells in humans14 and sheep contain muscarinic receptors15 (and references therein), 
which raise [Ca2+]i and increase ciliary beat frequency when stimulated.
Airway ENaC activity is influenced in multiple ways, as expected for the key channel that gates the large 
electro-chemical driving force for Na+ influx into the cell, with resulting profound effects on transmembrane 
ion and fluid transport. Indeed, the hyperpolarization that occurs when ENaC closes is an efficient way to 
induce anion secretion, because the recycling of Na+ requires 4 times more energy than the recycling of Cl−16. 
Accordingly, factors reported to alter ENaC activity include multiple components of the cytosol17,18 and of the air-
way surface liquid (ASL), including proteases and anti-proteases19–21. Importantly, many of the regulatory factors 
in ASL are mainly provided by the glands22.
Although inhibition of ENaC is the most obvious way to inhibit absorption, there is evidence for other mech-
anisms. In sheep trachea, Acevedo23 observed biphasic Isc responses to ACh with properties like those seen pre-
viously in bronchioles. Surprisingly, however, a biphasic Isc response with corresponding increases and decreases 
in conductance was still observed after permeabilizing the apical membrane with amphotericin and imposing a 
K+ gradient, suggesting that ACh was transiently activating and then inhibiting basolateral K+ channels under 
these conditions.
With this background, we re-examined cholinergic effects on airway mucosal Isc with a view to understanding 
its generality and physiological significance.
Results
Carbachol inhibited ENaC-dependent Isc stimulation in four species. Isc was measured across 
excised tracheal epithelia of 5 species: humans, sheep, pigs, ferrets, and rabbits. Isc was also measured across 
planer sheets of cultured primary human bronchial epithelia (HBE) and H441 human small airway cells. The 
basic procedure was to measure resting Isc and then the Isc response to carbachol added either before or after 
benzamil. In all tissues except ferret tracheas the resting Isc was inhibited 50~90% by benzamil; in ferrets benza-
mil inhibited < 20% of the resting Isc.
In sheep, 100 μ M basolateral carbachol stimulated a transient increase (t1/2 = 88.9 ± 10.6 sec, n = 15) in Isc 
followed by a sustained decrease (t1/2 > 30 min, Fig. 1A, bottom Isc trace). When conditions were reversed and 
benzamil was added first, it produced a sustained decrease in Isc as expected, and addition of carbachol now 
stimulated only the transient increase in Isc; additional benzamil was without effect (Fig. 1A, top Isc trace). Results 
for sheep are summarized in Fig. 1B and Supplementary Table S.1. Carbachol inhibited the benzamil-sensitive 
(ENaC-dependent) Isc by 80 ± 3% (n = 15, 13 sheep, P < 0.0001, Fig. 1B), whereas carbachol given after benzamil 
produced an initial transient increase (167 ± 52%, n = 3 sheep, P = 0.015) followed by a sustained increase in Isc 
(38 ± 29%, n = 3 sheep, n.s. P = 0.14) (Fig. 1B). Neither of these increases were sufficient to restore the original 
Isc.
Basolateral carbachol also inhibited ENaC-dependent (benzamil-sensitive) Isc in pig, human (Fig. 1B), some 
ferret tracheas (Supplementary Figure 1C) and in primary HBE cultures (see below). Apical carbachol had no 
consistent effect in any of these preparations (Supplementary Figure 1B). Carbachol inhibition of sheep and pig 
airways occurred with concentrations as low as 1 μ M, but inhibition at that concentration developed slowly, mak-
ing it difficult to study. In sheep, 100 μ M carbachol rapidly and reliably induced inhibition; in the other species 
1 mM carbachol was required to consistently inhibit ENaC-dependent Isc, and in ferrets even that concentration 
gave inconsistent results. (Note that ferret experiments were done in the presence of cartilage, and ferrets also had 
the smallest response to benzamil, see below).
In human large airways 76.7 ± 11.7% of the Isc was benzamil-sensitive, and carbachol inhibited 39 ± 3.3% 
of that Isc (n = 4 human subjects). In pig tracheas 58.8 ± 2.6% of the Isc was ENaC-dependent and carbachol 
inhibited 44.2 ± 4.7% of that Isc (n = 10 pigs). In ferret tracheas only 17.3 ± 4.2% of Isc, was inhibited by benza-
mil (n = 32, 16 ferrets). When carbachol was added first, it inhibited the Isc in only 3 of 8 ferrets by 36 ± 20.5% 
(Supplementary Figure 1C).
Carbachol inhibited ENaC-dependent Isc in primary cultures of HBE cells. Stimulation of HBE 
cells with 1 mM carbachol produced an Isc drop in all monolayer HBE cell inserts (n = 6, Figs 1B and 2 and 
Supplementary Table S.1). The initial transient increase in Isc was lacking or small. (The transient increase in 
human airways was also small, see below). In contrast with explanted airways, benzamil subsequently caused a 
second large drop in Isc (top Isc trace) to ~zero Isc, and when benzamil was added first it almost abolished the 
Isc (87.4 ± 6.9%, n = 3), again in contrast with explanted airway tissues, where ~30% of the original Isc remained 
after benzamil. Isc recovered slowly after wash out to 60~70% of the Isc which could be inhibited with repeated 
benzamil (Fig. 2, top Isc trace). If benzamil was added first (Fig. 2, bottom Isc trace), the subsequent washout 
increased Isc and part of the recovered Isc was sensitive to 1 mM carbachol. To our knowledge this is the first 
demonstration of carbachol-induced inhibition of primary HBE cells.
Inhibition was unchanged after reducing anion transport. The decline in Isc following carbachol 
might partially result from inhibition of anion secretion, although that interpretation is not consistent with the 
small increases in Isc seen when carbachol was added after benzamil. To further explore a role for anion secre-
tion, we stimulated sheep trachea with carbachol in normal Krebs-Ringer bicarbonate (KRB) buffer and in a 
buffer designed to block anion transport (HEPES for replacing HCO3− and 100 μ M bumetanide to block, Na+/
K+/2Cl− cotransporter, NKCC). These conditions reduce carbachol-stimulated gland secretion by ~90%24. No 
significant difference in carbachol-induced inhibition of the ENaC-dependent Isc was observed when anion 
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transport was reduced by bumetanide + HEPES (the residual ENaC-dependent ENaC Isc: 11.6 ± 2.7 in KRB and 
11.4 ± 2.6 μ A/cm2, P = 0.8, n = 6 from 4 sheep), while the transient Isc increase was greatly reduced in HEPES + 
bumetanide buffer (14.7 ± 2.4 in KRB and 7.8 ± 2.8 μ A/cm2 in HEPES + Bm) (Figure 3).
Carbachol inhibition of Isc is mediated by muscarinic receptors. Carbachol, like acetylcholine, stim-
ulates both muscarinic and nicotinic receptors. Furthermore, the high concentrations needed to see inhibition 
Figure 1. Carbachol inhibits Na+ transport across airway surface epithelia. (A,B) Ussing chamber Isc 
responses (1 mV pulse every 20 seconds) from a matched pair of sheep tracheal mucosa to drug additions 
indicated by arrows. (A) Carbachol (100 μ M, basolateral, ‘Carb’) followed by 10 μ M apical benzamil (Bz) (top 
Isc trace). Drugs given in reverse order: carbachol following benzamil (bottom Isc trace). (B) Summary of 
carbachol-induced ENaC inhibition in airways from three different species (n = 4, 13, and 10 human, sheep, 
and pig, respectively) and primary human bronchial epithelial cells (HBE, n = 9). Carbachol concentration was 
1 mM except for sheep (100 μ M). Bz-first represents the benzamil treatment preceded carbachol treatment and 
the bars are showing peak of the transient increase (open bar), sustained (black bar) Isc responses-induced by 
carbachol, and Isc response-inhibited by benzamil (grey bar).
Figure 2. Carbachol inhibition of Isc in primary cultures of human bronchial epithelial cells. Top trace: 
ENaC-dependent Isc is partially inhibited by 1 mM carbachol and reduced to zero with 10 μ M benzamil. Both 
kinds of inhibition were partially reversed by washing. Bottom trace: all Isc was inhibited by benzamil but not 
by carbachol. Unlike animal tracheas, an initial transient Isc increase to 1 mM carbachol was either small or 
absent in HBE cells (n = 9 monolayer inserts).
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of Isc in some preparations raised a concern about off-target effects. To determine if Isc inhibition was mediated 
by muscarinic receptors, we compared effects of the muscarinic antagonist atropine and the nicotinic antagonist 
hexamethonium bromide on carbachol inhibition of ENaC–dependent Isc. When atropine was added near the 
maximum of carbachol-induced inhibition it led to recovery with a time course similar to that seen after wash-out 
of carbachol (Fig. 4A). When atropine (1 or 10 μ M) was added basolaterally before carbachol, it abolished the Isc 
decreases to carbachol (Fig. 4B) (n = 4 sheep and 2 pigs). In contrast, hexamethonium bromide up to 100 μ M had 
no effect on carbachol-induced inhibition (Supplementary Figure 2A), and nicotine (1 mM, basolateral) failed to 
alter Isc in pig or sheep tracheal mucosa (3 pigs and 2 sheep, Supplementary Figure 2B).
Apical ATP inhibited ENaC-dependent Isc, but was not required for carbachol-induced inhibi-
tion. In several systems13,18,25,26, apical ATP inhibits amiloride-sensitive Isc. To investigate the possibility that 
carbachol-induced inhibition might be mediated by release of ATP, sheep tracheas were pretreated with 100 μ M 
ATP before carbachol addition. As previously described in other systems, ATP decreased the ENaC-dependent 
Isc. However, subsequent addition of 100 μ M carbachol produced an additional decrease in Isc (Fig. 5A, top Isc 
trace). When ATP was added after carbachol-induced inhibition had plateaued, it produced no further inhibi-
tion (Fig. 5A, bottom Isc trace). Summary data (Fig. 5B) show that ATP alone reduced ENaC-dependent Isc by 
48.4 ± 8.1% (n = 3 sheep, P = 0.016) and subsequent carbachol addition almost abolished the remaining ENaC–
dependent Isc (P = 0.001). These results show that carbachol inhibits ENaC-dependent Isc more effectively than 
does ATP, but do not eliminate the possibility that ATP release is a component of carbachol-induced inhibition. To 
evaluate that possibility we added 10 U/ml apical apyrase (which catalyzes the hydrolysis of ATP), to sheep and pig 
airway mucosa (n = 7 from 4 sheep and one pig) prior to adding carbachol or ATP. Apyrase pretreatment abolished 
ATP-induced inhibition but had no effect on the carbachol-induced inhibition (Figure 5C and D). Thus, if ATP is 
released into the ASL by carbachol its inhibitory effects are occlusive with other inhibitory mechanisms.
Carbachol failed to inhibit Isc in rabbit trachea and in the human H441 cell line. In rabbit tra-
cheas ~50% of total Isc was benzamil-sensitive (ENaC-dependent) prior to stimulation (n = 3 rabbits). When rab-
bit tracheal mucosa was treated with 100 μ M carbachol either to basolateral or apical side before or after benzamil, 
it produced no change in the Isc (Fig. 6A, n = 4 from 3 rabbits). This lack of responsiveness by rabbit tracheas is 
consistent with an earlier report that studied excised tracheas27. However, cultured rabbit tracheal cells responded 
to carbachol with increased Isc and [Ca2+]i28. We confirmed that rabbit tracheal Isc was inhibited by apical ATP 
(Supplementary Figure 3A), as first shown by Iwase and colleagues25.
H441 cells are human small airway cells that express functional ENaC. H441 cells developed robust 
ENaC-dependent Isc (~93% of their starting Isc: 38.5 ± 4.5 to 2.8± 0.8 μ A/cm2, n = 7 inserts) but they did not 
respond to basolateral or apical application of 1 mM carbachol (Fig. 6B, n = 6 inserts). Apical ATP produced 
no inhibition, instead causing a sustained increase in Isc of 6 or 12 μ A/cm2 (n = 2 inserts, Supplementary 
Figure 3. Na+ absorption but not anion secretion was inhibited by cholinergic stimulation. (A) (top 
trace, anion transport inhibitors present, bottom trace, control buffer) In sheep trachea, ENaC-dependent Isc 
inhibition by carbachol persisted after anion secretion was blocked by 100 μ M basolateral bumetanide (Bm) 
plus HCO3− replacement by HEPES with pure O2 supply. The transient Isc increase by carbachol was greatly 
reduced in the bumetanide and HEPES condition. (B) Average magnitude of residual benzamil-sensitive Isc 
in sheep airways after carbachol; control (KRB, Krebs-bicarbonate) vs. HEPES/Bm buffers (n = 6 each, from 4 
sheep).
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Figure 3B, top Isc trace). However, ENaC-dependent Isc was inhibited by 4–16 μ A/cm2 by thapsigargin, which 
elevates [Ca2+]i. (Supplementary Figure 3B, bottom Isc trace, n = 2 inserts).
These observations indicate that rabbit tracheal and H441 cells also have mechanisms for inhibiting 
ENaC-dependent Isc, but rabbit tracheal cells either lack muscarinic receptors or fail to couple them to pathways 
that inhibit the ENaC-dependent Isc, while H441 cells lack mechanisms to couple either muscarinic or purinergic 
receptors to inhibition of ENaC-dependent Isc.
Proteases and anti-proteases influenced Isc in H441 cells and airway mucosa. We previously 
proposed that airway submucosal glands could participate in the regulation of ENaC activity by secreting ENaC 
regulating factors, such as serine protease inhibitors, onto the airway surface when glands are stimulated21,29. In 
our present study we found that the serine protease inhibitor aprotinin significantly reduced ENaC-dependent 
Isc in H441 cell monolayers when 30 μ g/ml was applied apically (control: from 48.8 ± 3.6 to 41.2 ± 2.4 and apro-
tinin treated: from 47.2 ± 3.8 to 21.2 ± 2.3 μ A/cm2, P = 0.001, n = 4 inserts). Trypsin partially counteracted 
carbachol-induced inhibition in pig and sheep airways (Supplementary Figure 3C and D). These results are con-
sistent with our earlier interpretations21,29 and other reports19,30.
Phospholipase-C activation was not required for carbachol-induced inhibition. A phospholipase-C 
pathway has been implicated in the inhibition of ENaC by flagellin31. To determine if cholinergic inhibition 
of ENaC requires PLC, we tested carbachol-induced inhibition ± the PLC inhibitor, U73122, in sheep and pig 
tracheas. Apical + basolateral U73122 (10 μ M) had no effect on carbachol inhibition of ENaC-dependent Isc 
(Supplementary Figure 4A).
CFTR activation with forskolin did not affect carbachol inhibition of ENaC-dependent Isc. 
CFTR interactions with ENaC have been controversial3,32. To look for possible interactions, we activated 
or inhibited CFTR prior to carbachol stimulation and noted effects on ENaC-dependent Isc. The residual 
ENaC-dependent Isc after carbachol was not significantly different in the presence (2.7 ± 0.6 μ A/cm2) or absence 
(2.8 ± 0.5 μ A/cm2) of 10 μ M forskolin pre-treatment (n = 5, 4 sheep, Supplementary Figure 4B).
Discussion
Main findings. Cholinergic stimulation causes both gland secretion and increased rates of mucociliary clear-
ance (MCC)7,8. Because mucus clearance rates increase as the depth of ASL increases1,2, increased MCC after 
cholinergic stimulation could result simply from increased ASL depth following gland secretion. This effect will 
Figure 4. Carbachol inhibition of Isc is mediated by muscarinic receptors. (A) Carbachol (100 μ M) 
inhibition of Isc in sheep trachea recovered slowly after washout (top Isc trace) and after application of atropine 
(Atrp, 10 μ M, basolateral, bottom Isc trace). Inhibition could be repeated (top Isc trace). (B) Dose-dependent 
block of cholinergic effects on Isc by atropine. Sheep tracheas treated with 1 or 10 μ M atropine prior to 1 
to 100 μ M carbachol. Both the initial increase and the later decrease in Isc are blocked. Atropine block was 
observed in 6 experiments with sheep (n = 3) and pigs (n = 2, Supplementary Figure 2A).
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be counterbalanced by absorption, which in cultured epithelial cells increases as fluid depth increases1,2. This is 
a means of eventually restoring conditions to the basal state, but during the need for rapid clearance we hypoth-
esized that the effects of glandular secretion on MCC could be amplified by switching the surface epithelia from 
fluid absorption to fluid secretion—indeed in one system this has been shown directly by inhibiting ENaC with 
benzamil7. How is this normally accomplished in vivo? The main point of this paper is that long lasting inhibition 
of ENaC-dependent fluid absorption is the most important factor in the switch of surface epithelia from absorption 
to secretion.
In the present experiments we explored the generality and physiological significance of cholinergic inhibition 
of ENaC-dependent Isc by testing the effects of cholinergic stimulation on Isc in seven types of airway prepara-
tions that display ENaC-dependent Isc. Of these, five also displayed cholinergic inhibition of ENaC-dependent 
Isc. The exceptions were rabbit trachea and the H441 human small airway cell line; we suspect but did not estab-
lish that these cells lack muscarinic receptors.
Comparison with apparently contradictory results. Some prior studies do not report cholinergic inhi-
bition of ENaC-dependent Isc. A previous study of dog tracheas found no effect of acetylcholine on inhibition of 
inward Na+ current, and only a slight inhibition of Na+ flux33. Dogs, like rabbits, may lack this response, but the 
concentration of ACh was less and the measurement duration shorter than we used, so dog tracheas will need to 
be re-examined using comparable conditions to establish this point.
In an elegant study, results opposite to those reported here were found in cultured rat alveolar type II cells, 
where carbachol activated ENaC activity34. Different actions of muscarinic agents in different cell types are not 
contradictory. Indeed, if viewed functionally, they are complementary actions to remove fluid from the airways. 
Fluid removal from the lung alveoli by A2 cells occurs by direct fluid absorption, which was increased by systemic 
carbachol34. However, for the airways, with their vastly reduced surface area compared to alveoli, the mechanism 
for fluid removal is primarily via mucociliary clearance, which is accelerated when ENaC-dependent absorption 
is inhibited7 (Joo, unpublished observation with ex vivo ferret tracheas). Thus, paradoxically, inhibition of airway 
epithelial absorption will increase the rate of fluid (mucus) clearance from the airways to restore ASL depth. As 
Figure 5. Apical ATP is not required for carbachol-induced inhibition of Isc. (A) Inhibition of Isc across 
sheep trachea by 100 μ M apical ATP before (top trace) and after (bottom trace) 100 μ M basolateral carbachol. 
Inhibition of Isc by ATP is much smaller after carbachol treatment. Benzamil (10 μ M) was applied apically.  
(B) Summary of ATP results in sheep airways (n = 3); *,**significantly different from control, “after,” P < 
0.05 and P < 0.005, respectively. (C) In sheep trachea, apyrase pretreatment (10 U/ml, apical) had no effect 
on carbachol induced inhibition of ENaC-dependent Isc. (D) By contrast, in sheep trachea apyrase (top 
trace) abolished ATP induced inhibition of ENaC-dependent Isc (shown without apyrase in bottom trace). 
Representative traces, n = 6 experiments from 4 sheep.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:20735 | DOI: 10.1038/srep20735
mentioned above, this mechanism can’t operate in closed, cell culture systems, where fluid absorption is the only 
means for decreasing depth.
Mechanisms of carbachol inhibition of ENaC-dependent Isc: apical mediators. An efficient way 
to couple gland secretion to inhibition of epithelial surface absorption would be to have the glands themselves 
secrete factors to inhibit ENaC22 (and references therein). This hypothesis is supported by evidence that ENaC 
is inhibited by multiple factors in the ASL17–20, many of which are abundant in glands6,21,22,29, For example, the 
BPI fold protein SPLUNC1 inhibits ENaC activity and fluid absorption of airway surface epithelia and has been 
proposed as the major endogenous ENaC regulator of upper airways surface epithelia20. BPI fold proteins are 
most highly expressed in submucosal glands in the upper airways35,36 and are the most abundantly detected innate 
defense proteins in pure mucus secreted from human airway submucosal glands22. In Ussing chambers the ASL is 
diluted extensively so that fluctuations in ASL soluble factors are unlikely to play a significant role in the responses 
we observed. However, to show that such factors can in principle participate in the cholinergic response we 
showed that the antiproteases, aprotinin decreased Isc in H441 cells and the protease trypsin increased it in sheep 
and pig airway. It remains necessary to demonstrate directly that stimulating glands inhibits benzamil-sensitive 
Isc and if so, to assess the importance of their role.
The logic is compelling that glandular secretions increase mucus clearance rates both by direct secretion of 
mucus and by switching the surface epithelia to a secretory mode by inhibiting ENaC-dependent fluid absorption.
Mechanisms of carbachol inhibition of ENaC-dependent Isc: basolateral mediators. In spite of 
controversy about whether epithelia are innervated37–39, human14 and sheep airway ciliated cells15 express mus-
carinic receptors, and 4 of the 5 species tested plus cultured HBE cells responded to the muscarinic agonist 
carbachol. We do not know the cellular mechanisms that intervene between activation of muscarinic receptors 
and inhibition of ENaC-dependent Isc, but the combined results of many investigators added to our own make 
it clear that multiple mechanisms must be involved. It needs to be emphasized that there is no direct evidence 
from any study that ENaC activity of tracheal epithelial cells is decreased by cholinergic stimulation, although 
that is the assumption. ENaC PO can be decreased in tracheal cells by ATP17 and increased in cultured A2 cells 
by muscarinic stimulation34. But even in the careful analysis of A2 cells only the early links in the pathway from 
muscarinic receptors were described34.
Figure 6. Carbachol did not inhibit ENaC-dependent Isc in rabbit airways or H441 cells. (A) Rabbit tracheal 
preparations were treated with 100 μ M carbachol basolaterally (C-bl) and apically (C-ap) after (top trace) and 
before (bottom trace) 10 μ M apical benzamil (Bz) as indicated by arrows. Representative Ussing Isc records from 
n = 3 rabbits. (Apical ATP (100 μ M) did inhibit ENaC-dependent Isc, see Supplementary Figure 3A). (B) H441 
human small airway Clara epithelial cells failed to respond to 1 mM carbachol applied to both sides of the filter 
(top trace), in spite of having a large ENaC-dependent Isc (bottom trace). Representative traces from 6 H441 cell 
inserts.
www.nature.com/scientificreports/
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An alternative or additional mechanism is the inhibition of basolateral K+ channels23. Because the anion 
secretion that continues in the presence of carbachol (Fig. 1, Supplementary Figures 5A and B) is sensitive to the 
anion channel inhibitor, niflumic acid, this inhibition can only be partial, since some residual K+ conductances 
are necessary to sustain the anion secretion. In addition to these potential mechanisms, ENaC-dependent Isc is 
modulated by the membrane potential, so that cholinergic activation of anion conductances will reduce the driv-
ing force for Na+ entry independent of any effect on ENaC number or PO. In sum, detailed patch clamp and cell 
biological analyses of carbachol-induced inhibition of ENaC-dependent Isc are warranted and feasible now that 
we have demonstrated the phenomenon in cultured cells HBE cells, but our focus has been on the physiological 
relevance, not the mechanism.
Limitations of this study. In addition to the limitations discussed above, methods beyond Isc stud-
ies will be required to establish mechanisms. The high concentrations of carbachol that were required to see 
ENaC-dependent Isc are puzzling, because it is unlikely that these occur physiologically, even as part of strong 
parasympathetic activation during the lung defense reflex40. This is especially so since direct cholinergic synapses 
on airway epithelia have not been described and the source of ACh is likely to be more diffuse. We are confident 
that these are not off-target effects, because atropine eliminated the high dose carbachol effects (Supplementary 
Figure 2A-bottom Isc trace). For cholinergic mediation of gland secretion, co-transmitters such as VIP produce 
markedly synergistic effects6, so it is possible that our experiments lack co-factors needed to amplify inhibition 
by carbachol. Also, at concentrations of carbachol below threshold for most preparations, those that responded 
showed a very slowly developing inhibition that eventually reached a level similar to that produced rapidly by 
much higher concentrations (Supplementary Figure 6). The variability and very slow development of responses 
to lower concentrations precluded its further study, but it remains possible that intact airways might exert tonic 
control of fluid absorption with low levels of acetylcholine (and perhaps with other co-transmitters).
Physiological relevance: parasympathetic coordination of optimal mucus clearance. This work 
was influenced by earlier work showing that ACh increased ciliary beat frequency via an M3 receptor present in 
airway epithelial cells15, by evidence that carbachol stimulated gland secretion and mucociliary clearance rates 
in pig7 and ferret8 tracheas, and that benzamil speeded MCC rates after anion transport had been diminished7. 
We hypothesize that parasympathetic stimulation in vivo will also inhibit ENaC-dependent, Na+-mediated fluid 
absorption, and help switch the balance of epithelia transport to net secretion, thus augmenting gland secretion 
and increased ciliary beat frequency to speed mucus clearance. If this interpretation is correct, it suggests caution 
in the use of inhaled anti-cholinergic agents to treat patients with obstructive pulmonary diseases, since these 
might actually slow MCC41.
Materials & Methods
Airway tissue procurement. Human tracheal scraps from donors were obtained from lung transplants 
harvested less than 2 h post-mortem at Stanford Hospital. The protocol for handling human airway tissues was 
approved and informed consent was obtained from all participants prior to the study (Stanford University-IRB 
protocol#: 11638). Postmortem (< 1 hr) tracheas from young male and female Yorkshire pigs (30~50 kg), young 
male Suffolk-Rambouillet sheep (~70 kg), New Zealand White rabbits at the age of 5~6 months, and 3~10 months 
old M. Putorius ferrets were obtained from the animal facility at Stanford University after acute experiments 
unrelated to our studies. All protocols for handling animal tissues at Stanford were approved by Administrative 
Panel on Laboratory Animal Care (Stanford’s Institutional Animal Care and Use Committee: IACUC protocol#: 
10048). Methods for both human and animal tissues were carried out in accordance with approved guidelines. 
Harvested tissues were placed in cold PhysioSolTM (Hospira, IL) after removal for transport to the laboratory 
and then transferred to ice-cold Krebs Ringer bicarbonate (KRB) buffer gassed with 95% O2 and 5% CO2 and kept 
until use. The KRB buffer composition was 115 mM NaCl, 2.4 mM K2HPO4, 0.4 mM KH2PO4, 25 mM NaHCO3, 
1.2 mM MgCl2, 1.2 mM CaCl2, and 10 mM Glucose (pH 7.2 at room temperature) adjusted to ~290 mosM with a 
Wescor vapor pressure osmometer. The Krebs buffer contained 1.0 μ M indomethacin to minimize endogenously 
generated prostaglandins during tissue preparation. Where HCO3−-free bathing buffer solution was used, HCO3− 
was replaced by HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, and gassed with 100% O2. Tracheal 
mucosa for Ussing chamber experiments were carefully dissected from underlying cartilage while those from 
rabbits and ferrets were used intact without dissecting cartilage and connective tissues and only cartilaginous 
portions of trachea were used.
Cell culture. The human airway surface epithelial cell line21, H441, was maintained in a T25 tissue culture flask 
containing a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F-12 nutrient mixture supplemented 
with 10% fetal bovine serum (Sigma, MO), 100 μ g/ml streptomycin, 100 units/ml penicillin, and 2 mM glutamine 
at 37° C in a humidified atmosphere containing 5% CO2. Cells were passaged once at 7~10 days and seeded 
on HPC (human placental collagen, Sigma)-coated filters (Snapwells, Corning-Costar). To provide an optimal 
air-interface cultures, the serum medium was switched with 2% Ultroser-G (BioSepra, Cergy, France), a serum 
substitute, containing medium in cells grown on filters 3~4 days after seeding. Human airway primary cell cul-
tures used in this study were generously provided by Philip Karp, Jonathan Widdicombe and Walter Finkbeiner.
Electrophysiology. Human and animal airway tissue preparations and cultured cells on filters were mounted 
in EasyMount Ussing chambers (Physiologic Instruments, CA) with exposed surface areas of 0.07~1.13 cm2 
depending on the preparation, and were bathed in KRB buffer at 37 °C with a continuous 95% O2 and 5% CO2 
gas supply, except for HCO3−-free buffer solutions which were gassed with pure O2. Transepithelial short-circuit 
current (Isc) was measured using a VCC-600 voltage clamp (Physiologic Instruments, CA) and Isc data were 
obtained and displayed with PowerLab Chart4 software (ADInstruments, CA). Total tissue conductance was 
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calculated by applying Ohm’s law to the Isc deflection resulting from 1 mV pulse across the tissues/cell cultures 
every 20 sec during the experiment (Supplementary Table S.1).
Reagents. Chemicals were obtained from Sigma/Aldrich (St. Louise, MO) and were made fresh or main-
tained at − 20 °C as aliquots of stock concentrations. Stock solutions of carbachol, ATP, apyrase (ATP diphos-
phohydrolase), aprotinin, trypsin, and hexamethonium bromide were made in sterilized deionized water 
and bumetanide, an inhibitor of Na+/K+/2Cl− transporter in alkaline solution while benzamil, CFTRinh172, 
GlyH101, thapsigargin, U73122 (a phospholipase C, PLC, inhibitor), and atropine were dissolved in dimethyl 
sulfoxide (DMSO, Me2SO). Carbachol-induced Isc responses were indistinguishable from those produced by ace-
tylcholine (Supplementary Figure 1A). Therefore, we used carbachol (a metabolically non-hydrolyzable analog) 
instead of acetylcholine to avoid potential variability that could be caused by differing levels of acetylcholinest-
erase across species. Benzamil was chosen because it is a more potent inhibitor of ENaC than amiloride, giving 
maximal inhibition at 10 μ M42.
Statistics. Data are presented as mean ± S.E.M. unless indicated otherwise. Student’s t-test was used to com-
pare means of different treatment groups. ENaC-dependent Isc was calculated either by subtracting the starting 
Isc from the Isc after benzamil (benzamil-first, no carbachol pretreatment) or by subtracting starting Isc from Isc 
after benzamil (but carbachol treatment- preceded) (Fig. 1B and Supplementary Table 1). Benzamil-sensitive Isc 
is alternately referred to as ENaC-dependent Isc.
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